Measured Risk Portfolios’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
5,930
-40
-0.7% -$9.32K 1.34% 34
2026
Q1
$1.46M Sell
5,970
-882
-13% -$205K 1.6% 33
2025
Q4
$1.42M Sell
6,852
-1,201
-15% -$237K 1.41% 32
2025
Q3
$1.49M Buy
8,053
+40
+0.5% +$6.85K 1.39% 33
2025
Q2
$1.22M Buy
8,013
+236
+3% +$36.3K 1.18% 36
2025
Q1
$1.29M Sell
7,777
-243
-3% -$38K 1.38% 36
2024
Q4
$1.16M Buy
+8,020
New +$1.24M 1.21% 38

Other funds holding JNJ

Measured Risk Portfolios's JNJ Position: Q2 2026 in Review

Measured Risk Portfolios reduced its Johnson & Johnson (JNJ) stake by 0.67% in Q2 2026, selling an estimated $9.32K and leaving 5,930 shares worth $1.51M. The position accounts for 1.34% of the portfolio, ranked #34.

Measured Risk Portfolios first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Measured Risk Portfolios held 5,930 shares of Johnson & Johnson worth $1.51M as of Q2 2026.
  • Measured Risk Portfolios sold 40 Johnson & Johnson shares in Q2 2026, an estimated $9.32K.
  • Johnson & Johnson made up 1.34% of Measured Risk Portfolios's portfolio in Q2 2026, its #34 holding.
  • Measured Risk Portfolios first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Measured Risk Portfolios's 13F filing for Q2 2026, filed 12 Aug 2026.